Trine Opstad Andersen

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis

Anette Løken Eilertsen, Else Høibraaten, Ingrid Os et al. · Maturitas · 2005 · 60 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia

Per Ole Iversen, Patricia D. E. Groot, Nils Hjeltnes et al. · British Journal of Haematology · 2002 · 48 citations · Full text

The Effects of Hormone Replacement Therapy on Hemostatic Variables in Women with Angiographically Verified Coronary Artery Disease

Else Høibraaten, Ingrid Os, Ingebjørg Seljeflot et al. · Thrombosis Research · 2000 · 44 citations

Cardiovascular Disease, Hemostatic Variables, Coronary Artery Disease +9

A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)

Anders Erik Astrup Dahm, Trine Opstad Andersen, F. R. Rosendaal et al. · Journal of Thrombosis and Haemostasis · 2005 · 43 citations

Inflammation, Thrombosis, Blood Platelet +12

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

BjOslash rn Bendz, John‐Bjarne Hansen, Trine Opstad Andersen et al. · British Journal of Haematology · 1999 · 35 citations · Full text